{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-24-000166","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.288528+00:00","generated_at":"2026-05-31T09:41:07.220231+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"BioRestorative Therapies issues Q2 2024 results press release; specific figures not provided","bullets":["Press release announcing Q2 2024 financial results was issued on August 13, 2024.","Press release includes a business update and details for a conference call to discuss results.","No specific financial data (revenue, EPS, etc.) are available from the filing text provided.","The filing serves as a notice that results were released, but exhibit content is missing."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-24-000166","json":"https://secwatch.observer/filing/0001021771-24-000166.json","markdown":"https://secwatch.observer/filing/0001021771-24-000166.md","text":"https://secwatch.observer/filing/0001021771-24-000166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000166/0001021771-24-000166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000166/brt81324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:41:07.220231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}